Login to Your Account

Middle-Income Markets Important for Pharma

Coordinated Government Policies Will Foster Biotech Innovation

By Peter Winter

Monday, November 5, 2012

There is no doubt that the biotechnology industry is truly global and that emerging markets have become extremely important for pharmaceutical companies. That is not surprising considering the fact that countries such as China, Brazil, Russia and India will represent 30 percent of the projected total global pharmaceutical sales of about $1.2 trillion in 2016, up from 20 percent of the total of $955 billion in 2011.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription